Treatments:Neuraminidase Inhibitor Pharmacokinetics References

From Proteopedia

(Difference between revisions)
Jump to: navigation, search

David Canner (Talk | contribs)
(New page: References for Neuraminidase Inhibitor Pharmacokinetics<ref>A Randomized, Placebo Controlled, 3-Way Crossover Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Rep...)
Next diff →

Current revision

References for Neuraminidase Inhibitor Pharmacokinetics[1][2]

  1. ↑ A Randomized, Placebo Controlled, 3-Way Crossover Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Repeat Dose Zanamivir (RELENZA™) 10mg Administered Twice Daily for 5 Days by Rotacap/Rotahaler Compared to ROTADISK™/DISKHALER™ in Healthy Subjects, Study No: NAI113625, 2009
  2. ↑ Oo C, Hill G, Dorr A, Liu B, Boellner S, Ward P. Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1-5 years. Eur J Clin Pharmacol. 2003 Sep;59(5-6):411-5. Epub 2003 Aug 9. PMID:12910331 doi:http://dx.doi.org/10.1007/s00228-003-0639-6

Proteopedia Page Contributors and Editors (what is this?)

David Canner

Retrieved from "http://52.214.119.220/wiki/index.php/Treatments:Neuraminidase_Inhibitor_Pharmacokinetics_References"
Personal tools